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SUMMARY 
The role of nutritional factors on heme synthesis and their influence on the development of anemia in 
the bone marrow during lead exposure is unclear. Previous reports suggested that pteridines could regulate 
the formation of uroporphyrinogen, a step midway along the heme synthetic pathway. Studies were under- 
taken to determine if pteridines could modulate lead inhibition of uroporphyrinogen synthesis in erythroid 
precursor cells. Pteroylpolyglutamates of various glutamate chain lengths were tested for the ability to 
protect against lead inhibition of uroporphyrinogen I (URO) synthase prepared from murine erythroleuke- 
mia cells (MELC). Pteroylpentaglutamate, the major endogenous polyglutamate form by chain length 
found to be present in MELC, afforded rapid and specific protection of URO synthase against lead inhibi- 
tion. MELC are expected to be a useful in vitro model for studying the role of endogenous folates on 
uroporphyrinogen synthesis and heme formation in erythroid precursor cells following lead exposure. 
INTRODUCTION 
The role of various physiological factors that regulate heme synthesis and/or influ- 
ence the development of anemia in the bone marrow during lead (Pb) exposure has 
been sparsely investigated. Previous studies in liver demonstrated that oxidized po- 
lyglutamate derivatives of folic acid protected against Pb inhibition of uroporphy- 
rinogen I (URO) synthase (EC 4.3.1.8) [l]. As a result of the rather low levels of URO 
synthase activity found in liver and other tissues. it is believed that the synthesis of 
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uroporphyrinogen may be potentially rate-limiting for the biosynthesis of heme. 
Consequently, the endogenous folate content and regulation of pteroylpolyglutamate 
synthesis/catabolism are anticipated to be important factors modulating the suscepti- 
bility of bone marrow heme synthesis to inhibition by Pb [2]. 
Most previous studies concerning the etiology of drug/toxicant-associated anemia 
and its relationship to the biosynthesis of heme have been conducted with the mature 
red blood cell, which is not actively engaged in heme synthesis. It is anticipated that 
more relevant information could be obtained by focusing study on the bone marrow. 
It is known that premature erythroid precursor cells are highly susceptible to the 
toxic effects of Pb. As a result of the complex cellular heterogeneity of bone marrow 
in vivo, controlled study of this cellular target is rather difficult. Murine erythroleuke- 
mia cells (MELC) are erythroid precursor cells which. when cultured in the presence 
of certain chemicals (e.g. DMSO, hexamethylene-bis(acetamide) [HMBA]) [3,4], un- 
dergo changes similar to normal erythrocyte maturation, including the synthesis of 
heme and hemoglobin [5]. It is anticipated that MELC will be a useful in vitro model 
to study drug/toxicant interactions during erythropoiesis. In the present study, this 
in vitro system was evaluated for its potential usefulness as a model to study folate 
regulation of uroporphyrinogen synthesis and heme formation in bone marrow dur- 
ing Pb exposure. 
MATERIALS AND METHODS 
Cell culture 
The murine erythroleukemia cell line (MELC), clone 745A. was obtained from the 
Institute for Medical Research, Camden, NJ. Spinner cultures were maintained at 
37°C in Iscove’s minimum essential medium supplemented with 5 9;: (v/v/) defined bo- 
vine calf serum (Hyclone Laboratories, Inc.. Logan, UT). Induction of differentia- 
tion was achieved by addition of a stock solution of hexamethylene-bis(acetamide) 
(HMBA) (Sigma Chemical Co., St. Louis, MO) to a final medium concentration of 
3 mM and maintenance of cultures for 4 days. 
Subcellular fractionation 
MELC pellets were lysed in distilled deionized water and homogenized in 50 mM 
Tris-HCl buffer (pH 8.0). After sequential centrifugation, the resulting 100000 x 
g supernatant (cytosol) served as the enzyme source. MELC cytosol was dialyzed for 
24 h at 4°C against 100 x volume of buffer with 4 exchanges. Protein content was 
determined by the method of Lowry et al. [6]. 
Uroporphyrinogen I (URO ) synthase activity 
Cytosolic URO synthase activity was measured by a modification [7] of the method 
of Strand et al. [8]. Cytosol was incubated with 100 PM porphobilinogen (PBG) (Por- 
phyrin Products, Logan, UT) in 50 mM Tris-HCl/SO mM KC1 (pH 7.8) at 37°C for 
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45 min. Following the addition of ethylacetate/acetic acid (2: l), 1 .O N HCl was added 
and the mixture shaken. After phase separation and standing for 30 min in room 
light, porphyrin fluorescence in the lower aqueous phase was determined and com- 
pared to a uroporphyrin I standard (Porphyrin Products) using a spectrophotofluor- 
ometer. 
&Aminolevulinic acid dehydratase (ALA-D) activity 
Cytosolic ALA-D activity was measured by the method of Gibson et al. [9]. The 
product, porphobilinogen (PBG), was measured spectrophotometrically (553 nm) 
after reaction with Ehrlich’s reagent using a mM extinction coefficient of 61. 
Effects of lead andpteroylpolyglutamates (PteGlu,) on enzyme activities 
Pteroylpolyglutamates in oxidized form were obtained from Dr. N.G. Nair, Uni- 
versity of South Alabama Medical Sciences Foundation, Mobile, AL. Pb as lead ace- 
tate and pteroylpolyglutamates as free acids were added to the incubation mixtures 
as described in the text. Pteroylpolyglutamates exhibited 95% homogeneity by gluta- 
mate chain length as determined by high-performance liquid chromatography 
(HPLC) as described by Shane [lo]. 
Pteroylpolyglutamate distribution in MELC 
Endogenous pteroylpolyglutamates in MELC extracts were quantitatively cleaved 
to p-aminobenzoylpolyglutamates and separated according to glutamate chain 
length by HPLC as described by Shane [lo]. 
Statistics 
Data were analyzed by Student’s t-test to determine the significance of difference 
between means. 
RESULTS AND DISCUSSION 
The effect of Pb on uroporphyrinogen synthase was studied in MELC. The results 
showed that URO synthase activity in untreated cytosol was unaffected by incuba- 
tion with 50 pM Pb (Table I). Dialysis of cytosol rendered URO synthase activity 
sensitive to Pb, showing an 80% decrease in activity in Pb-treated cytosol compared 
to controls. Thus, MELC cytosol exhibited similarities to hepatic cytosol with respect 
to the presence of a dialyzable factor conferring protection on URO synthase against 
inhibition by Pb [l]. The dialyzable factor was postulated to be a derivative of pte- 
roylpolyglutamic acid. 
To test this possibility, various pteroylpolyglutamates were tested for the ability 
to protect URO synthase against inhibition by Pb in dialyzed cytosol. Although all 
of the pteroylglutamates tested decreased control URO synthase activity somewhat, 
only pteroylpentaglutamate (PteGluS) was capable of conferring protection against 
TABLE I 
EFFECT OF DIALYSIS AND THE ADDITION OF PTEROYLGLUTAMATES OF VARIABLE 
CHAIN LENGTHS (PteGlu,) ON INHIBITION OF UROPORPHYRINOGEN (URO) SYNTHASE 
BY LEAD 
Condition UK0 synthase activity,’ 
(nmol URO,‘mg protein;45 min) 
No dialysis 
Dialysis 





Control 50 pM Pb 
6.70+0.30 6.88 +0.09 
6.65 * Il.08 1.53*0.16 
5.41 kO.13 0.77*0.17 
4.35kO.09 0.75 *0.05 
4.25 * 0.05 0.84 + 0.08 
4.25+0.05 3.4’&0.05* 








~lValucs arc the means k SEM for 3 determinations. 
hPteroylglutamates were added to dialyzed cytosol at a concentration of 100 PM. 
*Significantly different from dialysis;Pb, Pi 0.01. 
Pb inhibition (Table I). A rather high concentration (100 ,vM) of PteGlus was re- 
quired to protect URO synthase from Pb inhibition. One possible explanation is that 
the endogenous protective factor is a more potent biological derivative of PteGlus 
[I I]. The results in Figure I showed that the protection of URO synthase from Pb 
inhibition by PteGlus was rapid, with near control levels of uroporphyrinogen forma- 
tion observed in the first 5 min of incubation. Reduced glutathione (GSH), a dialyz- 
able sulfhydryl compound, was also found to protect against Pb inhibition of URO 
synthase but only at millimolar concentrations. This concentration exceeded normal 
cytosolic GSH levels by at least IOO-fold (data not shown). 
The specificity of PteGlus for protection of URO synthase against Pb inhibition 
was examined by testing the ability of PteGluS to protect another heme biosynthetic 
enzyme known to be extremely sensitive to Pb, S-aminolevulinic acid dehydratase 
(ALA-D) [9]. PteGlus failed to protect against a Pb-mediated decrease in ALA-D ac- 
tivity (Table II), suggesting that the protective effect was specific for URO synthase 
and not merely a Pb-chelating function [I]. 
Analysis of the distribution of endogenous pteroylglutamates in MELC revealed 
a mixture of pteroylmono-, tetra-, penta- and hexaglutamate, with pentaglutamate 
predominating (> 50% of total endogenous pteroylglutamate) (Fig. 2). Thus, by glu- 
tamate chain length, the pteroylpolyglutamate which protected URO synthase 
against Pb inhibition was the predominant endogenous form. Identification of the 
exact structure of this endogenous pteridine should aid in elucidating the specific 
mechanism of protection of URO synthase. Such studies are currently in progress. 
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Fig. 1. Effect of dialysis and pteroylpentaglutamate addition on the time-dependent formation of uropor- 
phyrinogen in the presence of Pb. MELC cytosol (ND = non-dialyzed: D = dialyzed; D + PCS =dialyzed 
+ 100 PM PteGluZ) was incubated with porphobilinogen substrate at 37°C in the absence or presence 
of Pb acetate (50 PM) and the reaction terminated at 5. IO. I5 and 20 min. Values are the means f SEM 
for 3 determinations. 
96 
TABLE II 
EFFECT OF THE ADDITION OF PTEROYLPENTAGLUTAMATE (PteGlui) ON INHIBlTlC)N 
OF 6-AMINOLEVULINIC ACID DEHYDRATASE (ALA-D) ACTIVITY BY LEAD 
Condition ALA-D activity’ 
(nmol PBG/mg protein/h) 
Control 50 /tM Pb 
No dialysis 25.09+0.35 I I 89 f 0.48 
Dialysis 64.0010.40 33.75+0.61 
Dialysis + PteGltQ 42.67 f I. 14 1X.36,1.44 
dValues are the means k SEM for 3 determinattons. 
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Fig. 2. Distribution of endogenous ptcroylpolyglutamates (PteGlu,) in differentiating MELC cultures. 
MELC cultures were maintained in HMBA-containing medium for 4 days. Endogenous folates in MELC 
extracts were quantitatively cleaved to p-aminobenzoylpolyglutamates and analyzed by HPLC as dr- 
scribed by Shane [IO]. Distribution of polyglutamate chain length is expressed as the percentage of total 
endogenous pteroylglutamatr (1.23+0.18 nmolig cells). Values are the means i SEM for 3 determina- 
tions. 
These initial studies demonstrate the potential usefulness of MELC to study the 
role of endogenous folate content and the regulation of pteroylpolyglutamate synthe- 
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